KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Invested Capital: 2019-2025

Historic Invested Capital for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to $559.8 million.

  • Ginkgo Bioworks Holdings' Invested Capital fell 29.85% to $559.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $559.8 million, marking a year-over-year decrease of 29.85%. This contributed to the annual value of $716.1 million for FY2024, which is 34.73% down from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Invested Capital stood at $559.8 million for Q3 2025, which was down 8.67% from $613.0 million recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' 5-year Invested Capital high stood at $1.7 billion for Q4 2022, and its period low was $356.4 million during Q2 2021.
  • For the 3-year period, Ginkgo Bioworks Holdings' Invested Capital averaged around $965.0 million, with its median value being $833.1 million (2024).
  • In the last 5 years, Ginkgo Bioworks Holdings' Invested Capital surged by 341.13% in 2022 and then tumbled by 44.59% in 2024.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Invested Capital (Quarterly) stood at $1.6 billion in 2021, then climbed by 10.95% to $1.7 billion in 2022, then slumped by 36.91% to $1.1 billion in 2023, then crashed by 34.73% to $716.1 million in 2024, then fell by 29.85% to $559.8 million in 2025.
  • Its Invested Capital stands at $559.8 million for Q3 2025, versus $613.0 million for Q2 2025 and $647.4 million for Q1 2025.